Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement On December 24, 2025, Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” and the “company”) and NeoImmuneTech, I
Other Events. On December 30, 2025, Emmaus issued a press release announcing the License Agreement and related matters. A copy of the press release is filed as
Financial Statements and Exhibits (d) Exhibits See the accompanying Index to Exhibits, which information is incorporated herein by reference. 1 SIGNATURES Pursu